KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Income from Continuing Operations (2016 - 2025)

West Pharmaceutical Services' Income from Continuing Operations history spans 17 years, with the latest figure at 128200000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations changed 0.08% year-over-year to 128200000.0; the TTM value through Dec 2025 reached 479300000.0, changed 0.27%, while the annual FY2025 figure was 479300000.0, 0.27% changed from the prior year.
  • Income from Continuing Operations for Q4 2025 was 128200000.0 at West Pharmaceutical Services, down from 137900000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 183000000.0 in Q2 2022 and bottomed at 86400000.0 in Q1 2025.
  • The 5-year median for Income from Continuing Operations is 134000000.0 (2023), against an average of 136995000.0.
  • The largest annual shift saw Income from Continuing Operations soared 120.76% in 2021 before it crashed 32.43% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 147700000.0 in 2021, then plummeted by 32.43% to 99800000.0 in 2022, then skyrocketed by 33.97% to 133700000.0 in 2023, then decreased by 4.19% to 128100000.0 in 2024, then increased by 0.08% to 128200000.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Income from Continuing Operations are 128200000.0 (Q4 2025), 137900000.0 (Q3 2025), and 126800000.0 (Q2 2025).